�ٺ���Ƶ

News from �ٺ���Ƶ Health

�ٺ���Ƶ Nabs 5% Operating Margin As Patient Discharges Rise. (Crain's New York Business)

Paywalled* (7/30) �ٺ���Ƶ Health achieved a 5% operating margin in the last quarter, driven by increased revenue from patient care and pharmaceutical sales. �ٺ���Ƶ Health “has increased its revenue more than 14% since the same time in 2023, which spokesman Steve Ritea, senior director, Media Relations attributed to continued growth in patient volume.” �ٺ���Ƶ Health “consistently reports higher profitability than other hospitals in New York City.”

Patients In Public Hospital-Based Opioid Program More Likely To Stay In Treatment, Study Shows. (Crain's New York Business)

Paywalled* (7/29) “More patients with opioid addiction are getting into treatment thanks to” the Consult for Addiction Treatment and Care in Hospitals “program at New York City Health + Hospitals that aims to fill a gap in specialized treatment for substance use disorder,” with patients who “went through the city-funded program were eight times more likely to start treatment and seven times more likely to remain on medication for 30 days, according to a study released Monday by NYU Grossman School of Medicine.” Jennifer McNeely, MD, associate professor, Departments of Population Health, and Medicine, Division of General Internal Medicine and the study’s prime author, said, “That kind of addictions-focused treatment essentially never happens in the hospital unless you have a program like this.” NYU Grossman “School of Medicine received a $2.75 million grant from the National Institute on Drug Abuse to study the effectiveness of the initiative over three years in collaboration with Health + Hospitals” in “the first major randomized trial of hospital-based programs for opioid use disorder treatment.”

Blood Tests May Have An Edge Spotting Alzheimer’s. (Axios)

(7/29) Arjun Masurkar, MD, PhD, assistant professor, Departments of Neurology, and Neuroscience and Physiology, described blood tests as “very exciting,” but mentioned he doesn’t use them in clinical practice yet, stating, “They’re not truly ready for prime time just yet,” and adding that even if he wanted to use them, New York has restrictions on the tests.

Anxiety May Increase Risk Of Dementia, Study Finds. (CNN International)

(7/29) A new study suggests that anxiety may nearly triple the risk of developing dementia in later years, with Joel Salinas, MD, MBA, clinical assistant professor, Department of Neurology, the Pearl I. Barlow Center for Memory Evaluation and Treatment and founder and chief medical officer of Isaac Health, stating that the findings underscore “the importance of addressing anxiety early and consistently.”

Social Media Bill Gets Its Day In The Senate. (Politico)

(7/29) Researchers in Florida and New York, including Joseph J. Palamar, MPH, PhD, associate professor, Department of Population Health, are collaborating with a lab north of Philadelphia to develop near real-time intelligence on emerging illicit drugs through the National Drug Early Warning System, supported by the National Institute on Drug Abuse, by monitoring discussions on Reddit and surveying people at various public locations.

Expert On How Fibroids Impact Women’s Health, Available Treatments. (CBS News)

(7/29) “July marks Fibroid Awareness Month and Taraneh Shirazian, MD, associate professor, Department of Obstetrics and Gynecology, Division of Minimally Invasive Gynecologic Surgery, “joined ‘CBS Mornings’ to discuss the condition and alternative treatments.”

Also reporting are West Palm Beach, FL (7/29) and (7/29).

Primary-Progressive MS: 6 Top Technology Recommendations. (Everyday Health)

(7/29) A review of research indicates that mindfulness-based interventions are effective at improving mental well-being in people with multiple sclerosis (MS), with Leigh E. Charvet, PhD, professor, Department of Neurology, saying, “Research studies suggest that mindfulness meditation practice, and reducing distress in general, may improve overall quality of life and may reduce symptom burden in MS.”

Compensating Organ Donors & The Psychology Of Smell. (WHYY-TV Philadelphia)

Philadelphia (7/29) A proposal to offer a $50,000 tax credit to organ donors in the US, where many die waiting for transplants, raises ethical questions and is debated by Arthur L. Caplan, PhD, the Drs. William F. and Virginia Connolly Mitty Professor, Department of Population Health, Division of Medical Ethics, Dr. Gregory Hess, a physician and kidney transplant recipient, and Lauren Sheppard, who donated her kidney to a stranger a decade ago.

The AAIC Presents Lifetime Achievement Awards In Alzheimer’s Disease Research. (Practical Neurology)

(7/29) Ralph A. Nixon, MD, PhD, professor, Departments of Psychiatry, and Cell Biology, received the Khalid Iqbal Lifetime Achievement Award at the 2024 Alzheimer’s Association International Conference for his contributions as Director of the Center for Dementia Research at the Nathan S. Kline Institute, recognizing his leadership, research, and mentorship in advancing Alzheimer disease research.

What To Know About Chronic Kidney Disease In The Wake Of Suni Lee’s Diagnosis. (PopSugar)

(7/29) “The most common cause of kidney disease in the US is diabetes, says” David S. Goldfarb, MD, professor, Department of Medicine, Division of Nephrology, and Department of Neuroscience and Physiology, clinical chief, Division of Nephrology, NY Harbor VA Medical Center, adding, “That is the main cause of not just chronic kidney disease, but kidney failure as well.”

Surging Demand, Soaring Price Tags Lead To Fake Ozempic Doses. (Al Jazeera English)

(7/29) The global demand for GLP-1 agonists, including semaglutide, known by brand names Ozempic and Wegovy, has led to a rise in counterfeit versions causing hospitalizations, with Melanie R. Jay, MD, associate professor, Department of Medicine, Division of General Internal Medicine, and Department of Population Health, expressing concern, saying, “There’s all this advertising for other places where you can get it for a lot cheaper, and it’s impossible to know how safe these alternatives are.”

FDA Approves Blood Test For Colon Cancer Detection. (CBS News)

(7/29) The Food and Drug Administration approved a blood test intended to detect colorectal cancer, expanding screening options for the potentially deadly disease; CBS News chief medical correspondent Jonathan LaPook, MD, Mebane Professor of Gastroenterology, Department of Medicine, professor, Department of Population Health, said that a blood test is an attractive option for screening because “it’s relatively easy to do and there’s no ‘ick factor,’” though it will not replace colonoscopy, which remains the current gold standard for early detection.

The News Cycle Has Been Intense. Should You Be Hope-Scrolling Instead? (Yahoo! News)

(7/29) Thea Gallagher, PsyD, clinical associate professor, Department of Psychiatry, suggests muting social media accounts that cause negative feelings, even if they belong to friends, to avoid influencers who induce unnecessary consumerism or social comparison.

Alzheimer’s Blood Test Detects Disease With 90% Accuracy In Routine Doctors’ Appointments: Study. (Fox News)

(7/29) “medical contributor Marc K. Siegel, MD, clinical professor, Department of Medicine, Division of General Internal Medicine and Clinical Innovation “explains a new blood test that could lead to early detection of Alzheimer’s disease.”

In a separate embedded video, (7/29) “medical contributor Marc K. Siegel, MD, clinical professor, Department of Medicine, Division of General Internal Medicine and Clinical Innovation “joined ‘Fox & Friends’ to discuss the growing problem with the spread of carfentanil, which is 100 times more powerful than fentanyl.”